Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
暂无分享,去创建一个
Dennis R Burton | Raymond A Dwek | David J Harvey | D. Burton | R. Dwek | M. Crispin | K. Doores | D. Harvey | Max Crispin | Christopher N. Scanlan | Camille Bonomelli | Snezana Vasiljevic | Katie J Doores | Camille Bonomelli | Christopher N Scanlan | Snežana Vasiljevic
[1] T. Mizuochi,et al. Carbohydrate structures of the human-immunodeficiency-virus (HIV) recombinant envelope glycoprotein gp120 produced in Chinese-hamster ovary cells. , 1988, The Biochemical journal.
[2] Chi-Huey Wong,et al. Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN , 2008, Proceedings of the National Academy of Sciences.
[3] R. Dwek,et al. Monoglucosylated glycans in the secreted human complement component C3: implications for protein biosynthesis and structure , 2004, FEBS letters.
[4] F. Hanisch,et al. Protein-specific glycosylation: signal patches and cis-controlling peptidic elements , 2009, Biological chemistry.
[5] David F. Smith,et al. An Engineered Saccharomyces cerevisiae Strain Binds the Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody 2G12 and Elicits Mannose-Specific gp120-Binding Antibodies , 2008, Journal of Virology.
[6] D. Burton,et al. GP120: target for neutralizing HIV-1 antibodies. , 2006, Annual review of immunology.
[7] E. De Clercq,et al. Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro , 1991, Antimicrobial Agents and Chemotherapy.
[8] R. Dwek,et al. Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway. , 2006, Glycobiology.
[9] A. Trkola,et al. HIV sensitivity to neutralization is determined by target and virus producer cell properties , 2009, AIDS.
[10] John P. Moore,et al. Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function. , 2010, Virology.
[11] Peter D. Kwong,et al. The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120 , 2002, Journal of Virology.
[12] Lai-Xi Wang,et al. Binding of high-mannose-type oligosaccharides and synthetic oligomannose clusters to human antibody 2G12: implications for HIV-1 vaccine design. , 2004, Chemistry & biology.
[13] R. Dwek,et al. Exploiting the defensive sugars of HIV-1 for drug and vaccine design , 2007, Nature.
[14] R. Cummings,et al. Specificity of DC‐SIGN for mannose‐ and fucose‐containing glycans , 2006, FEBS letters.
[15] Douglas S Kwon,et al. DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.
[16] Jerome H. Kim,et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. , 2009, The New England journal of medicine.
[17] Lynn Morris,et al. Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? , 2009, Nature Medicine.
[18] K. Tomer,et al. Mass spectrometric characterization of glycosylation of hepatitis C virus E2 envelope glycoprotein reveals extended microheterogeneity of N-glycans , 2008, Journal of the American Society for Mass Spectrometry.
[19] Pauline M Rudd,et al. The impact of glycosylation on the biological function and structure of human immunoglobulins. , 2007, Annual review of immunology.
[20] G. Wiederschain,et al. Essentials of glycobiology , 2009, Biochemistry (Moscow).
[21] Tongqing Zhou,et al. Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120 , 2009, Science.
[22] D. Burton,et al. Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody. , 2007, Journal of molecular biology.
[23] K. Tomer,et al. Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. , 2000, Biochemistry.
[24] Young Do Kwon,et al. Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility , 2009, Proceedings of the National Academy of Sciences.
[25] J. Shiver,et al. Fully synthetic carbohydrate HIV antigens designed on the logic of the 2G12 antibody. , 2007, Journal of the American Chemical Society.
[26] Roland Contreras,et al. Structure and function in rhodopsin: High-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[27] Barbra A. Richardson,et al. Removal of a Single N-Linked Glycan in Human Immunodeficiency Virus Type 1 gp120 Results in an Enhanced Ability To Induce Neutralizing Antibody Responses , 2007, Journal of Virology.
[28] Pham Phung,et al. Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target , 2009, Science.
[29] Beda Joos,et al. Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol. , 2004, Virology.
[30] J. Mascola,et al. Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need? , 2009, Current opinion in HIV and AIDS.
[31] H. Katinger,et al. The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120 , 2002, Journal of Virology.
[32] D. Burton,et al. Antigenic mimicry of the HIV envelope by AIDS-associated pathogens , 2008, AIDS.
[33] W. Olson,et al. Toward fully synthetic carbohydrate-based HIV antigen design: on the critical role of bivalency. , 2004, Journal of the American Chemical Society.
[34] R. Dwek,et al. Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans. , 2010, Glycobiology.
[35] G. Pialoux,et al. [HIV vaccines]. , 2005, Presse medicale.
[36] R. Dwek,et al. Structural and quantitative analysis of N-linked glycans by matrix-assisted laser desorption ionization and negative ion nanospray mass spectrometry. , 2008, Analytical biochemistry.
[37] D. Burton,et al. Natural Resistance of Human Immunodeficiency Virus Type 1 to the CD4bs Antibody b12 Conferred by a Glycan and an Arginine Residue Close to the CD4 Binding Loop , 2008, Journal of Virology.
[38] R. Dwek,et al. Sequencing of N-linked oligosaccharides directly from protein gels: in-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography. , 1997, Analytical biochemistry.
[39] R. Doms,et al. A Yeast Glycoprotein Shows High-Affinity Binding to the Broadly Neutralizing Human Immunodeficiency Virus Antibody 2G12 and Inhibits gp120 Interactions with 2G12 and DC-SIGN , 2009, Journal of Virology.
[40] David F. Smith,et al. Antibodies against Manalpha1,2-Manalpha1,2-Man oligosaccharide structures recognize envelope glycoproteins from HIV-1 and SIV strains. , 2010, Glycobiology.
[41] Weixian Lu,et al. A time- and cost-efficient system for high-level protein production in mammalian cells. , 2006, Acta crystallographica. Section D, Biological crystallography.
[42] Xiping Wei,et al. Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2005, Journal of Virology.
[43] E. Go,et al. Glycosylation site-specific analysis of clade C HIV-1 envelope proteins. , 2009, Journal of proteome research.
[44] M. Schreiber,et al. N-Glycans in the gp120 V1/V2 domain of the HIV-1 strain NL4-3 are indispensable for viral infectivity and resistance against antibody neutralization , 2006, Medical Microbiology and Immunology.
[45] R. Dwek,et al. N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120 , 1996, Journal of virology.
[46] Martin A. Nowak,et al. Antibody neutralization and escape by HIV-1 , 2003, Nature.
[47] S. Kornfeld,et al. Assembly of asparagine-linked oligosaccharides. , 1985, Annual review of biochemistry.
[48] D. Stuart,et al. A Human Embryonic Kidney 293T Cell Line Mutated at the Golgi α-Mannosidase II Locus , 2009, The Journal of Biological Chemistry.
[49] Louise Royle,et al. Proposal for a standard system for drawing structural diagrams of N‐ and O‐linked carbohydrates and related compounds , 2009, Proteomics.